Pneumonia clinical trials

Explore recruiting pneumonia clinical trials.

Recruiting pneumonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pneumonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY)

Italy, Netherlands, France, Belgium, Estonia, Portugal +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SPARE : Evaluation of a therapeutic strategy to reduce the duration of antibiotic therapy for community-acquired alveolar pneumonia in children: a randomized controlled non-inferiority trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I single-blind clinical trial to evaluate the safety and local immune activation of a toll-like receptor 5 agonist (FLAMOD) administered by aerosol

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A prospective, multinational, multicenter, randomized, sequential, double-blind, placebo-controlled, phase 2a clinical study to assess the safety and pharmacokinetics (PK) of OMN6 in hospital-acquired bacterial pneumonia (HABP) or ventilated-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii complex (ABC).

Italy, Hungary, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Pneumonia trials by city

Pneumonia in Toronto Pneumonia in Vancouver Pneumonia in Montreal Pneumonia in Calgary Pneumonia in Edmonton Pneumonia in Ottawa Pneumonia in Winnipeg Pneumonia in Quebec City Pneumonia in Hamilton Pneumonia in Kitchener Pneumonia in London Pneumonia in Halifax Pneumonia in New York Pneumonia in Los Angeles Pneumonia in Chicago Pneumonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease